Works matching IS 19466234 AND DT 2021 AND VI 13 AND IP 613
Results: 6
ULK1 inhibition promotes oxidative stress–induced differentiation and sensitizes leukemic stem cells to targeted therapy.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 613, p. 1, doi. 10.1126/scitranslmed.abd5016
- By:
- Publication type:
- Article
A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 613, p. 1, doi. 10.1126/scitranslmed.abj1578
- By:
- Publication type:
- Article
Aberrant activation of m6A demethylase FTO renders HIF2α<sup>low/−</sup> clear cell renal cell carcinoma sensitive to BRD9 inhibitors.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 613, p. 1, doi. 10.1126/scitranslmed.abf6045
- By:
- Publication type:
- Article
CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's disease.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 613, p. 1, doi. 10.1126/scitranslmed.abe7104
- By:
- Publication type:
- Article
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 613, p. 1, doi. 10.1126/scitranslmed.abg9922
- By:
- Publication type:
- Article
APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 613, p. 1, doi. 10.1126/scitranslmed.abc9375
- By:
- Publication type:
- Article